• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

研究肝脏微环境中T细胞对嗜肝病毒的反应。

Studying T Cell Responses to Hepatotropic Viruses in the Liver Microenvironment.

作者信息

Lopez-Scarim Jarrett, Nambiar Shashank Manohar, Billerbeck Eva

机构信息

Division of Hepatology, Department of Medicine and Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

出版信息

Vaccines (Basel). 2023 Mar 17;11(3):681. doi: 10.3390/vaccines11030681.

DOI:10.3390/vaccines11030681
PMID:36992265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10056334/
Abstract

T cells play an important role in the clearance of hepatotropic viruses but may also cause liver injury and contribute to disease progression in chronic hepatitis B and C virus infections which affect millions of people worldwide. The liver provides a unique microenvironment of immunological tolerance and hepatic immune regulation can modulate the functional properties of T cell subsets and influence the outcome of a virus infection. Extensive research over the last years has advanced our understanding of hepatic conventional CD4+ and CD8+ T cells and unconventional T cell subsets and their functions in the liver environment during acute and chronic viral infections. The recent development of new small animal models and technological advances should further increase our knowledge of hepatic immunological mechanisms. Here we provide an overview of the existing models to study hepatic T cells and review the current knowledge about the distinct roles of heterogeneous T cell populations during acute and chronic viral hepatitis.

摘要

T细胞在嗜肝病毒的清除中发挥重要作用,但在慢性乙型和丙型肝炎病毒感染中也可能导致肝损伤并促进疾病进展,全球数以百万计的人受此影响。肝脏提供了一个独特的免疫耐受微环境,肝脏免疫调节可调节T细胞亚群的功能特性并影响病毒感染的结果。过去几年的广泛研究增进了我们对肝脏中传统CD4+和CD8+ T细胞以及非常规T细胞亚群及其在急性和慢性病毒感染期间在肝脏环境中功能的理解。新的小动物模型的最新发展和技术进步应进一步增加我们对肝脏免疫机制的认识。在此,我们概述了用于研究肝脏T细胞的现有模型,并回顾了关于异质性T细胞群体在急性和慢性病毒性肝炎中不同作用的当前知识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a31c/10056334/812e7a4b32c9/vaccines-11-00681-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a31c/10056334/812e7a4b32c9/vaccines-11-00681-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a31c/10056334/812e7a4b32c9/vaccines-11-00681-g001.jpg

相似文献

1
Studying T Cell Responses to Hepatotropic Viruses in the Liver Microenvironment.研究肝脏微环境中T细胞对嗜肝病毒的反应。
Vaccines (Basel). 2023 Mar 17;11(3):681. doi: 10.3390/vaccines11030681.
2
Immune outcomes in the liver: Is CD8 T cell fate determined by the environment?肝脏中的免疫结果:CD8 T 细胞的命运是否由环境决定?
J Hepatol. 2015 Oct;63(4):1005-14. doi: 10.1016/j.jhep.2015.05.033. Epub 2015 Jun 20.
3
T-cell responses in hepatitis B and C virus infection: similarities and differences.乙型和丙型肝炎病毒感染中的T细胞反应:异同
Emerg Microbes Infect. 2013 Mar;2(3):e15. doi: 10.1038/emi.2013.14. Epub 2013 Mar 27.
4
T-cell therapy for chronic viral hepatitis.慢性病毒性肝炎的T细胞疗法。
Cytotherapy. 2017 Nov;19(11):1317-1324. doi: 10.1016/j.jcyt.2017.07.011. Epub 2017 Aug 25.
5
Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8 T Cells.氨基酸替换 HLA-B*27 限制性 T 细胞表位可预防乙型肝炎病毒特异性 CD8 T 细胞识别。
J Virol. 2018 Jun 13;92(13). doi: 10.1128/JVI.01891-17. Print 2018 Jul 1.
6
Hepatic immune regulation and its involvement in viral hepatitis infection.肝脏免疫调节及其在病毒性肝炎感染中的作用。
Gastroenterology. 2014 May;146(5):1193-207. doi: 10.1053/j.gastro.2013.12.036. Epub 2014 Jan 8.
7
Immunology of hepatitis B and hepatitis C virus infections.乙型肝炎和丙型肝炎病毒感染的免疫学
Best Pract Res Clin Gastroenterol. 2008;22(6):1049-61. doi: 10.1016/j.bpg.2008.11.015.
8
Hepatic iNKT cells produce type 2 cytokines and restrain antiviral T cells during acute hepacivirus infection.在急性丙型肝炎病毒感染期间,肝脏不变自然杀伤T细胞产生2型细胞因子并抑制抗病毒T细胞。
Front Immunol. 2022 Sep 9;13:953151. doi: 10.3389/fimmu.2022.953151. eCollection 2022.
9
Mouse models of acute and chronic hepacivirus infection.急性和慢性丙型肝炎病毒感染的小鼠模型
Science. 2017 Jul 14;357(6347):204-208. doi: 10.1126/science.aal1962.
10
Role of non-hepatotropic viruses in acute sporadic viral hepatitis and acute-on-chronic liver failure in adults.非嗜肝病毒在成人急性散发性病毒性肝炎及慢加急性肝衰竭中的作用
Indian J Gastroenterol. 2015 Nov;34(6):448-52. doi: 10.1007/s12664-015-0613-0. Epub 2015 Nov 21.

引用本文的文献

1
CD4+ T cell help during early acute hepacivirus infection is critical for viral clearance and the generation of a liver-homing CD103+CD49a+ effector CD8+ T cell subset.在急性肝病毒感染早期,CD4+ T 细胞的辅助作用对于病毒清除和生成肝脏归巢的 CD103+CD49a+效应性 CD8+ T 细胞亚群至关重要。
PLoS Pathog. 2024 Oct 11;20(10):e1012615. doi: 10.1371/journal.ppat.1012615. eCollection 2024 Oct.
2
Τ cell-mediated adaptive immunity in the transition from metabolic dysfunction-associated steatohepatitis to hepatocellular carcinoma.从代谢功能障碍相关脂肪性肝炎向肝细胞癌转变过程中的T细胞介导的适应性免疫
Front Cell Dev Biol. 2024 May 7;12:1343806. doi: 10.3389/fcell.2024.1343806. eCollection 2024.
3

本文引用的文献

1
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro.慢性乙型肝炎中表型 CD8 T 细胞特征分析,以预测 HBV 特异性 CD8 T 细胞对体外功能恢复的易感性。
Gut. 2023 Nov;72(11):2123-2137. doi: 10.1136/gutjnl-2022-327202. Epub 2023 Jan 30.
2
Activation of CD4 T cells during prime immunization determines the success of a therapeutic hepatitis B vaccine in HBV-carrier mouse models.在初次免疫期间激活 CD4 T 细胞决定了治疗性乙型肝炎疫苗在乙肝携带者小鼠模型中的成功。
J Hepatol. 2023 Apr;78(4):717-730. doi: 10.1016/j.jhep.2022.12.013. Epub 2023 Jan 9.
3
Glutaminolysis of CD4 T Cells: A Potential Therapeutic Target in Viral Diseases.
CD4 T细胞的谷氨酰胺分解代谢:病毒疾病中的一个潜在治疗靶点。
J Inflamm Res. 2024 Feb 1;17:603-616. doi: 10.2147/JIR.S443482. eCollection 2024.
Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T cells.
慢性乙型肝炎患者开始抗病毒治疗后的肝脏纵向采样显示肝毒性 CD8+T 细胞。
J Clin Invest. 2023 Jan 3;133(1):e158903. doi: 10.1172/JCI158903.
4
The immune landscape in hepatitis delta virus infection-Still an open field.乙型肝炎 delta 病毒感染的免疫景观——仍然是一片未开垦的领域。
J Viral Hepat. 2023 Apr;30 Suppl 1:21-25. doi: 10.1111/jvh.13785. Epub 2023 Jan 11.
5
New insights into iNKT cells and their roles in liver diseases.固有淋巴细胞 1 型(iNKT)细胞及其在肝脏疾病中的作用的新见解。
Front Immunol. 2022 Oct 26;13:1035950. doi: 10.3389/fimmu.2022.1035950. eCollection 2022.
6
Emerging features of MAIT cells and other unconventional T cell populations in human viral disease and vaccination.人病毒性疾病和疫苗接种中 MAIT 细胞和其他非常规 T 细胞群体的新特征。
Semin Immunol. 2022 Nov;61-64:101661. doi: 10.1016/j.smim.2022.101661. Epub 2022 Oct 28.
7
Cholesterol accumulation on dendritic cells reverses chronic hepatitis B virus infection-induced dysfunction.树突状细胞内胆固醇蓄积逆转慢性乙型肝炎病毒感染诱导的功能障碍。
Cell Mol Immunol. 2022 Dec;19(12):1347-1360. doi: 10.1038/s41423-022-00939-1. Epub 2022 Nov 11.
8
Studying Hepatitis Virus-Host Interactions in Patient Liver Biopsies.研究患者肝活检中的肝炎病毒-宿主相互作用。
Viruses. 2022 Nov 10;14(11):2490. doi: 10.3390/v14112490.
9
Barriers to hepatitis C virus infection in mice.小鼠丙型肝炎病毒感染的屏障
Curr Opin Virol. 2022 Oct;56:101273. doi: 10.1016/j.coviro.2022.101273. Epub 2022 Oct 13.
10
HBV immune tolerance of HBs-transgenic mice observed through parabiosis with WT mice.通过与野生型小鼠联体观察 HBs 转基因小鼠的 HBV 免疫耐受。
Front Immunol. 2022 Sep 20;13:993246. doi: 10.3389/fimmu.2022.993246. eCollection 2022.